Page last updated: 2024-11-02

pentoxifylline and Stroke

pentoxifylline has been researched along with Stroke in 7 studies

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research Excerpts

ExcerptRelevanceReference
"To determine the effect of cilostazol on initial and absolute claudication distances, mortality and vascular events in patients with stable intermittent claudication."9.12Cilostazol for intermittent claudication. ( Brown, T; Cleanthis, M; Forster, RB; Mikhailidis, DP; Stansby, G; Stewart, M, 2021)
"To determine the effect of cilostazol (an antiplatelet treatment) on improving initial and absolute claudication distances, and in reducing mortality and vascular events in patients with stable intermittent claudication."8.90Cilostazol for intermittent claudication. ( Bedenis, R; Cleanthis, M; Mikhailidis, DP; Robless, P; Stansby, G; Stewart, M, 2014)
"To assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke."8.82Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Bath, PM; Bath-Hextall, FJ, 2004)
"The objective of this review was to assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke."8.80Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Asplund, K; Bath, FJ; Bath, PM, 2000)
"To determine the effect of cilostazol on initial and absolute claudication distances, mortality and vascular events in patients with stable intermittent claudication."5.12Cilostazol for intermittent claudication. ( Brown, T; Cleanthis, M; Forster, RB; Mikhailidis, DP; Stansby, G; Stewart, M, 2021)
"To determine the effect of cilostazol (an antiplatelet treatment) on improving initial and absolute claudication distances, and in reducing mortality and vascular events in patients with stable intermittent claudication."4.90Cilostazol for intermittent claudication. ( Bedenis, R; Cleanthis, M; Mikhailidis, DP; Robless, P; Stansby, G; Stewart, M, 2014)
"To assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke."4.82Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Bath, PM; Bath-Hextall, FJ, 2004)
"The objective of this review was to assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke."4.80Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Asplund, K; Bath, FJ; Bath, PM, 2000)
"Adult Wistar-Kyoto underwent a 2-h middle cerebral artery occlusion followed by an MRI study after 3 h of reperfusion, which consisted of T2- and diffusion-weighted techniques."1.35Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. ( Candelario-Jalil, E; Estrada, EY; Rosenberg, GA; Sood, RR; Taheri, S, 2008)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Brown, T1
Forster, RB1
Cleanthis, M2
Mikhailidis, DP2
Stansby, G2
Stewart, M2
Bedenis, R1
Robless, P1
Banfi, C1
Sironi, L1
De Simoni, G1
Gelosa, P1
Barcella, S1
Perego, C1
Gianazza, E1
Guerrini, U1
Tremoli, E1
Mussoni, L1
Bath, PM2
Bath-Hextall, FJ1
Sood, RR1
Taheri, S1
Candelario-Jalil, E1
Estrada, EY1
Rosenberg, GA1
Bath, FJ1
Asplund, K1
Handschu, R1
Garling, A1
Heuschmann, PU1
Kolominsky-Rabas, PL1
Erbguth, F1
Neundörfer, B1

Reviews

4 reviews available for pentoxifylline and Stroke

ArticleYear
Cilostazol for intermittent claudication.
    The Cochrane database of systematic reviews, 2021, 06-30, Volume: 6

    Topics: Aged; Bias; Cilostazol; Humans; Intermittent Claudication; Middle Aged; Myocardial Infarction; Pento

2021
Cilostazol for intermittent claudication.
    The Cochrane database of systematic reviews, 2014, Oct-31, Issue:10

    Topics: Aged; Cilostazol; Humans; Intermittent Claudication; Middle Aged; Myocardial Infarction; Pentoxifyll

2014
Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2004, Issue:3

    Topics: Brain Ischemia; Humans; Neuroprotective Agents; Pentoxifylline; Platelet Aggregation Inhibitors; Str

2004
Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Brain Ischemia; Humans; Neuroprotective Agents; Pentoxifylline; Platelet Aggregation Inhibitors; Str

2000

Other Studies

3 other studies available for pentoxifylline and Stroke

ArticleYear
Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3

    Topics: Animals; Brain Ischemia; Disease Models, Animal; Inflammation; Male; Pentoxifylline; Proteinuria; Ra

2004
Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2008, Volume: 28, Issue:2

    Topics: Animals; Benzyl Compounds; Blood-Brain Barrier; Dexamethasone; Drug Combinations; Infarction, Middle

2008
Acute stroke management in the local general hospital.
    Stroke, 2001, Volume: 32, Issue:4

    Topics: Diuretics; Echocardiography; Electrocardiography; Germany; Health Resources; Hospitals, Community; H

2001